Your browser doesn't support javascript.
loading
Pancreatic parenchymal changes seen on endoscopic ultrasound are dynamic in the setting of fatty pancreas: A short-term follow-up study.
Muftah, Abdullah A; Pecha, Robert L; Riojas Barrett, Margarita; Abidi, Wasif M; Patel, Kalpesh K; Keihanian, Tara; Othman, Mohamed O.
Afiliação
  • Muftah AA; Department of Internal Medicine, Baylor College of Medicine, Houston, Tx, USA.
  • Pecha RL; Department of Internal Medicine, Baylor College of Medicine, Houston, Tx, USA.
  • Riojas Barrett M; Department of Medicine, Division of Gastroenterology, Baylor College of Medicine, Houston, Tx, USA.
  • Abidi WM; Department of Medicine, Division of Gastroenterology, Baylor College of Medicine, Houston, Tx, USA.
  • Patel KK; Department of Medicine, Division of Gastroenterology, Baylor College of Medicine, Houston, Tx, USA.
  • Keihanian T; Department of Medicine, Division of Gastroenterology, Baylor College of Medicine, Houston, Tx, USA.
  • Othman MO; Department of Medicine, Division of Gastroenterology, Baylor College of Medicine, Houston, Tx, USA. Electronic address: mohamed.othman@bcm.edu.
Pancreatology ; 22(8): 1187-1194, 2022 12.
Article em En | MEDLINE | ID: mdl-36402715
ABSTRACT

OBJECTIVES:

The impact of fatty pancreas on pancreatic parenchymal changes is unclear. The aim of this study is to assess parenchymal alterations over time in patients with fatty pancreas (FP).

METHODS:

This is a retrospective study (2014-2021) of patients with FP identified on endoscopic ultrasound (EUS). Subjects with follow up imaging studies including Computed Tomography (CT) scan, Magnetic Resonance Imaging (MRI), and EUS at least two years after the initial EUS were included.

RESULTS:

A total of 39 patients with a mean age of 51.21 ± 12.34 years were included. Mean initial weight was 80.17 ± 17.75 kg. Diabetes, hepatic steatosis, and EPI were present in 15%, 46% and 33% of the patients at baseline, respectively. In 25 patients with available follow up EUS over 2.4 ± 0.76 years, 16% progressed to chronic pancreatitis (CP) and 24% had progressive parenchymal changes without meeting the criteria for CP. One patient progressed from focal to diffuse FP, while one patient had resolution of FP. In multivariate analysis, progressive parenchymal changes on EUS were associated with an increase in weight over time (p-value 0.04), independent of the effects of gender, alcohol, or tobacco.

CONCLUSION:

Progressive parenchymal changes were noted in 44%. Our result suggests that FP is a dynamic process with the possibility of progression or regression over time.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatopatias / Pancreatite Crônica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Pancreatology Assunto da revista: ENDOCRINOLOGIA / GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatopatias / Pancreatite Crônica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Middle aged Idioma: En Revista: Pancreatology Assunto da revista: ENDOCRINOLOGIA / GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos